Using the same experimental conditions (young female rats OVX 1 week before ischemia), we now show that a much lower dose of E2 and the selective GPR30 agonist G1, which does not bind to classical ERs [17], confer significant neuroprotection (Figure 2). Here, GPER1 is linked to ischemia.